Abstract
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES  (2011)

The use of primary circulating prostate cells to detect prostate cancer in men with a serum PSA > 4.0ng/ml: evidence, utility and cost-benefit

Murray N.P.; Reyes E.; Orellana N.; Badinez, L; Tapia P.

Keywords: biopsy, prostate cancer, circulating prostate cells, cost-benefit